| Literature DB >> 34448887 |
Ben Fluck1, Keefai Yeong2, Radcliffe Lisk2, Hazel Watters2, Jonathan Robin3, David Fluck4, Christopher H Fry5, Thang S Han6.
Abstract
The Blue Book published by the British Orthopaedic Association and British Geriatrics Society, together with the introduction of National Hip Fracture Database Audit and Best Practice Tariff, have been influential in improving hip fracture care. We examined ten-year (2009-2019) changes in hip fracture outcomes after establishing an orthogeriatric service based on these initiatives, in 1081 men and 2891 women (mean age = 83.5 ± 9.1 years). Temporal trends in the annual percentage change (APC) of outcomes were identified using the Joinpoint Regression Program v4.7.0.0. The proportions of patients operated beyond 36 h of admission fell sharply during the first two years: APC = - 53.7% (95% CI - 68.3, - 5.2, P = 0.003), followed by a small rise thereafter: APC = 5.8% (95% CI 0.5, 11.3, P = 0.036). Hip surgery increased progressively in patients > 90 years old: APC = 3.3 (95% CI 1.0, 5.8, P = 0.011) and those with American Society of Anaesthesiologists grade ≥ 3: APC = 12.4 (95% CI 8.8, 16.1, P < 0.001). There was a significant decline in pressure ulcers amongst patients < 90 years old: APC = - 17.9 (95% CI - 32.7, 0.0, P = 0.050) and also a significant decline in mortality amongst those > 90 years old: APC = - 7.1 (95% CI - 12.6, - 1.3, P = 0.024). Prolonged length of stay (> 23 days) declined from 2013: APC = - 24.6% (95% CI - 31.2, - 17.4, P < 0.001). New discharge to nursing care declined moderately over 2009-2016 (APC = - 10.6, 95% CI - 17.2, - 2.7, P = 0.017) and sharply thereafter (APC = - 47.5%, 95%CI - 71.7, - 2.7, P = 0.043). The rate of patients returning home was decreasing (APC = - 2.9, 95% CI - 5.1, - 0.7, P = 0.016), whilst new discharge to rehabilitation was increasing (APC = 8.4, 95% CI 4.0, 13.0; P = 0.002). In conclusion, the establishment of an orthogeriatric service was associated with a reduction of elapsed time to hip surgery, a progressive increase in surgery carried out on high-risk adults and a decline in adverse outcomes.Entities:
Keywords: Discharge destination; Join-point analysis; Length of stay; Mortality; Temporal trends
Mesh:
Year: 2021 PMID: 34448887 PMCID: PMC8784364 DOI: 10.1007/s00223-021-00906-4
Source DB: PubMed Journal: Calcif Tissue Int ISSN: 0171-967X Impact factor: 4.333
Fig. 1Annual number of patients admitted to hospital with a hip fracture between 2009 and 2019. Numbers of patients admitted from their own home are in white font and the total annual numbers are in red font (A); annual distribution of operative management of hip fractures (B)
Outcomes of 3972 patients undergoing surgery for a hip fracture
| n | % | |
|---|---|---|
| ≥ 36 h | 814 | 20.5 |
| Age > 90 years at operation (top quartile of age) | 993 | 25.0 |
| Grade 3 | 1666 | 42.0 |
| Grade 4 | 236 | 5.9 |
| Grade ≥ 3 (including 3 patients with grade 5) | 1905 | 48.0 |
| Spinal block with general anaesthetics | 1543 | 42.2 |
| Spinal block only | 668 | 18.3 |
| General anaesthetics only | 919 | 25.1 |
| Others | 526 | 14.4 |
| Arthroplasty | 2063 | 51.9 |
| IMN | 888 | 22.4 |
| SHS | 968 | 24.4 |
| THR hybrid and others | 51 | 1.3 |
| Failure to mobilise within one day of hip surgery | 398 | 10.0 |
| Hospital-acquired pressure ulcers | 132 | 3.3 |
| Mortality in hospital | 225 | 5.7 |
| Prolonged LOS in hospital (> 23 days)† | 991 | 25.0 |
| Returned back home | 1822 | 59.2 |
| New discharge to rehabilitation | 772 | 25.1 |
| New discharge to residential care | 66 | 2.1 |
| New discharge to nursing care | 138 | 4.5 |
| Other destinations | 123 | 4.0 |
| Antiresorptive therapy on admission | 183 | 4.6 |
| Newly prescribed antiresorptive therapy | 3296 | 83.0 |
| No antiresorptive therapy on discharge | 485 | 12.3 |
†Top quartile of LOS
Fig. 2Temporal trends in elapsed time to surgery beyond 36 h (A), hip surgery for patients older than 90 years (B) and those with ASA classification ≥ 3 (C)
Annual percentage change for amongst patients undergoing operation for hip fractures
| APC (%) | 95% CI | ||
|---|---|---|---|
| Elapsed time beyond ≥ 36 h (2009–2011) | − 54.1 | − 68.7, − 32.6 | 0.003 |
| Elapsed time beyond ≥ 36 h (2011–2019) | 6.3 | 0.9, 11.9 | 0.029 |
| Age at operation > 90 years | 3.3 | 1.0, 5.8 | 0.011 |
| ASA grade 3 | 10.4 | 6.7, 14.2 | < 0.001 |
| ASA grade 4 | 30.8 | 22.1, 40.0 | < 0.001 |
| ASA grade ≥ 3 | 12.4 | 8.8, 16.1 | < 0.001 |
| Arthroplasty | − 0.5 | − 1.8, 0.8 | 0.383 |
| IMN | 14.6 | 9.1, 20.3 | < 0.001 |
| SHS | − 13.5 | − 18.1, − 6.2 | < 0.001 |
| Failure to mobilise within 1 day of surgery | 2.9 | − 8.3, 15.4 | 0.494 |
| Hospital-acquired pressure ulcers (all) | − 12.5 | − 24.2, 1.1 | 0.065 |
| Hospital-acquired pressure ulcers (< 90 yrs) | − 17.9 | − 32.7, 0.0 | 0.050 |
| Hospital-acquired pressure ulcers (> 90 yrs) | − 8.4 | − 18.0, 2.3 | 0.105 |
| Mortality in hospital (all) | − 2.0 | − 6.2, 2.4 | 0.318 |
| Mortality in hospital (< 90 yrs) | 1.0 | − 7.2, 9.8 | 0.797 |
| Mortality in hospital (> 90 yrs) | − 7.1 | − 12.6, − 1.3 | 0.024 |
| LOS in hospital > 23 days (2009–2013) | − 1.0 | − 23.4, 29.5 | 0.927 |
| LOS in hospital > 23 days (2013–2018) | − 24.4 | − 37.4, − 8.5 | 0.013 |
| New discharge to nursing care (2009–2016) | − 10.6 | − 17.7, − 3.5 | 0.017 |
| New discharge to nursing care (2016–2018) | − 47.5 | − 71.7, − 2.7 | 0.043 |
| New discharge to rehabilitation | 8.4 | 4.0,13.0 | 0.002 |
| Returned back home | − 2.9 | − 5.1, − 0.7 | 0.016 |
| 1.9 | − 0.7, 4.5 | 0.113 |
Fig. 3Temporal trends in-hospital mortality in patients < 90 years (A) and > 90 years (B); and pressure ulcers in patients < 90 years (C) and > 90 years (D) after hip surgery
Fig. 4Median (interquartile range) length of stay in hospital (A) and proportions of patients who stayed longer than 23 days in hospital with a single join point (B) or with no join point (C)
Fig. 5New discharge to nursing care with a single join point (A) and no join point (B), and returned back home (C) or new discharge to rehabilitation (D) amongst patients who were admitted from their own home
Fig. 6Proportions of patients receiving anti-resorptive agents according to the milestones of service development